These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 400622)

  • 1. [The use of platelet aggregation inhibitor in nephrodialysis].
    Armani U; Piana A; Griffanti-Bartoli F; Altomonte F
    Arch Maragliano Patol Clin; 1979; 35(2):63-5. PubMed ID: 400622
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of a new platelet aggregation inhibitor, ticlopidine, in hemodialysis].
    Griffanti-Bartoli F; Altomonte F; Pitton L; Armani U; Piana A
    Arch Maragliano Patol Clin; 1979; 35(2):73-80. PubMed ID: 263724
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prostacyclin versus regional heparinisation during haemodialysis (author's transl)].
    Hory B; Saunier F; Roy C; Renevier A; Kieffer Y; Saint-Hillier Y; Perol C
    Nouv Presse Med; 1982 Jul 10-17; 11(32):2393-7. PubMed ID: 7050907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of prostaglandins in extracorporeal circulation and hemodialysis].
    Zaorska B
    Pol Tyg Lek; 1981 Jun; 36(23):857-60. PubMed ID: 7024949
    [No Abstract]   [Full Text] [Related]  

  • 5. [Study of an inhibitor of platelet aggregation [prostacycline] derived from rat arterial wall (author's transl)].
    García-Conde J; Merino J; Benet I
    Sangre (Barc); 1978; 23(5):526-34. PubMed ID: 368997
    [No Abstract]   [Full Text] [Related]  

  • 6. Hemodialysis with the stable prostacyclin analogue CG 4203.
    Maurin N
    Prog Clin Biol Res; 1987; 242():479-84. PubMed ID: 3313422
    [No Abstract]   [Full Text] [Related]  

  • 7. [Disorders of haemostasis in patients undergoing maintenance haemodialysis, with special reference to recurrent arteriovenous fistula thrombosis. Effects of dipyridamole (author's transl)].
    Jacques C; Drueke T; Nedellec J; Kremp O; Gazengel C
    Pathol Biol (Paris); 1976 Dec; 24 Suppl():27-32. PubMed ID: 827731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostacyclin can replace heparin in haemodialysis in dogs.
    Woods HF; Ash G; Weston MJ; Bunting S; Moncada S; Vane JR
    Lancet; 1978 Nov; 2(8099):1075-7. PubMed ID: 82090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of prostacyclin in regular dialysis therapy.
    Turney JH; Williams LC; Fewell MR; Parsons V; Weston MJ
    Proc Eur Dial Transplant Assoc; 1980; 17():318-22. PubMed ID: 7017677
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prospects of antiaggregant therapy in prevention of atherosclerosis].
    Strano A; Novo S
    G Ital Cardiol; 1979; 9(1):5-9. PubMed ID: 396163
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostacyclin: a solution to some problems of extracorporeal circulation. Experiments in greyhounds.
    Longmore DB; Bennett G; Gueirrara D; Smith M; Bunting S; Moncada S; Reed P; Read NG; Vane JR
    Lancet; 1979 May; 1(8124):1002-5. PubMed ID: 86720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the effectiveness of hemodialysis using only heparin or prostacyclin with heparin].
    Kuźniewski M; Sułowicz W
    Przegl Lek; 1990; 47(3):328-31. PubMed ID: 2236625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of prostacycline aerosol on the activity of blood platelets and lungs].
    Szczeklik A; Gryglewski R; Nizankowski R; Nizankowska E; Musiał J
    Pol Tyg Lek; 1979 Jul; 34(31):1225-7. PubMed ID: 388372
    [No Abstract]   [Full Text] [Related]  

  • 14. Heparin counteracts the antiaggregating effect of prostacyclin by potentiating platelet aggregation.
    Bertelé V; Roncaglioni MC; Donati MB; de Gaetano G
    Thromb Haemost; 1983 Apr; 49(2):81-3. PubMed ID: 6346573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prostaglandin for prevention of blood coagulation due to hemodialysis].
    Kitazawa K; Kobayashi K; Sugisaki T
    Nihon Rinsho; 1991 Dec; 49 Suppl():753-7. PubMed ID: 1808346
    [No Abstract]   [Full Text] [Related]  

  • 16. Antithrombotic management with a stable prostacyclin analogue during extracorporeal circulation.
    Maurin N
    Contrib Nephrol; 1991; 93():205-9. PubMed ID: 1802582
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of heparin and prostacyclin/heparin infusion on platelet aggregation in hemodialyzed patients.
    Kuźniewski M; Sułowicz W; Hanicki Z; Kus J; Nowogrodzka-Zagórska M; Kostka-Trabka E; Bieroń K; Debińska-Kieć A
    Nephron; 1990; 56(2):174-8. PubMed ID: 2243573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of coagulation during hemodialysis by a combination of the stable prostacyclin analogue CG 4203 and low-dose heparin.
    Maurin N; Ballmann M
    Clin Nephrol; 1988 Jul; 30(1):35-41. PubMed ID: 3061692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of prostacyclin (PGI2) on endotoxin shock and endotoxin-induced platelet aggregation in dogs.
    Fletcher JR; Ramwell PW
    Circ Shock; 1980; 7(3):299-308. PubMed ID: 7004660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased platelet sensitivity to prostacyclin during hemodialysis: an effect of platelet/heparin interaction?
    Knudsen F; Kristensen SD; Nielsen AH; Ring T; Stoffersen E
    Clin Nephrol; 1985 Feb; 23(2):107. PubMed ID: 3886225
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.